TNFRp55 modulates IL-6 and nitric oxide responses following Yersinia lipopolysaccharide stimulation in peritoneal macrophages

Immunobiology

Volumn 216, Issue 12, 2011, Pages 1322-1330

  Eliçabe, Ricardo J ^a,b   Arias, José L ^a,b   Rabinovich, Gabriel A ^c,d   Di Genaro, María Silvia ^a,b  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cytokines; LPS; Macrophages; TLR; TNFRp55; Yersinia enterocolitica

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; OUTER MEMBRANE PROTEIN; POLYMYXIN B; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR P55; UNCLASSIFIED DRUG; YERSINIA ENTEROCOLITICA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE; YERSINIA;

ANIMALS; ANTIGENS, BACTERIAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; POLYMYXIN B; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR DECOY RECEPTORS; YERSINIA ENTEROCOLITICA;

EID: 80054942780     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.05.009     Document Type: Article

References (42)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
2. Arranz A., Androulidaki A., Zacharioudaki V., Martinez C., Margioris A.N., Gomariz R.P., Tsatsanis C. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol. Immunol. 2008, 45:2970-2980.
3. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
4. Barrionuevo P., Beigier-Bompadre M., Ilarregui J.M., Toscano M.A., Bianco G.A., Isturiz M.A., Rabinovich G.A. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 2007, 178:436-445.
5. Beutler B., Hoebe K., Du X., Ulevitch R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol. 2003, 74:479-485.
6. Correa S.G., Sotomayor C.E., Aoki M.P., Maldonado C.A., Rabinovich G.A. Opposite effects of galectin-1 on alternative metabolic pathways of l-arginine in resident, inflammatory and activated macrophages. Glycobiology 2003, 13:119-128.
7. Degrandi D., Hoffmann R., Beuter-Gunia C., Pfeffer K. The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J Interferon Cytokine Res. 2009, 29:55-67.
8. Deng G.M., Verdrengh M., Liu Z.Q., Tarkowski A. The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum. 2000, 43:2283-2289.
9. Dennis V.A., Dixit S., O'Brien S.M., Alvarez X., Pahar B., Philipp M.T. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect. Immun. 2009, 77:1238-1245.
10. Di Genaro M.S., Cargnelutti D.E., Eliçabe J.R., Lacoste M.G., Valdéz S., Gómez N., de Guzmán A.M.S. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response. Rheumatology 2007, 46:590-596.
11. Di Genaro M.S., Muñoz E., Aguilera C., de Guzmán A.M.S. Yersinia enterocolitica O:8 and O:5 lipopolysaccharide arthritogenicity in hamsters. Rheumatology 2000, 39:73-78.
12. Di Genaro M.S., Waidmann M., Kramer U., Hitziger N., Bohn E., Autenrieth I.B. Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: Implications for the development of novel live carrier vaccines. Infect. Immun. 2003, 71:1804-1812.
13. Doyle S.L., O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 2006, 72:1102-1113.
14. Eliçabe R.J., Cargnelutti E., Serer M.I., Stege P.W., Valdez S.R., Toscano M.A., Rabinovich G.A., Di Genaro M.S. Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritis. J. Immunol. 2010, 185:4485-4495.
15. -/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 1997, 7:419-432.
16. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun. 2009, 33:222-230.
17. Feldmann M., Brennan F.M., Williams R.O., Woody J.N., Maini R.N. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2004, 18:59-80.
18. Freudenberg M.A., Tchaptchet S., Keck S., Fejer G., Huber M., Schütze N., Beutler B., Galanos C. Lipopolysaccahride sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008, 213:193-203.
19. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
20. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
21. Ikeda M., Hirose Y., Hamada R., Nakajima H., Miyoshi K., Matsumoto M., Seike M., Kodama H. Antisense phosphorothioate oligonucleotides to NF-kappaB (RelA/NF-kappaB1) decrease interleukin-8 secretion from cultured normal human epidermal keratinocytes. J. Dermatol. Sci. 2004, 35:230-232.
22. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
23. Iwanami K., Matsumoto I., Tanaka-Watanabe Y., Inoue A., Mihara M., Ohsugi Y., Mamura M., Goto D., Ito S., Tsutsumi A., Kishimoto T., Sumida T. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum. 2008, 58:754-763.
24. Jubier-Maurin V., Boigegrain R.A., Cloeckaert A., Gross A., Alvarez-Martinez M.T., Terraza A., Liautard J., Köhler S., Rouot B., Dornand J., Liautard J.P. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor production during infection of human macrophages. Infect. Immun. 2001, 69:4823-4830.
25. Kawai T., Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 2007, 13:460-469.
26. Kelchtermans H., Billiau A., Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008, 29:479-486.
27. Kim E.Y., Moudgil K.D. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol. Lett. 2008, 30:1-5.
28. Liu Y., Wang Y., Yamakuchi M., Isowaki S., Nagata E., Kanmura Y., Kitajima I., Maruyama I. Upregulation of Toll-Like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappaB activation. Infect. Immun. 2001, 69:2788-2796.
29. Michiels T., Wattiau P., Brasseur R., Ruysschaert J.M., Cornelis G. Secretion of Yop proteins by Yersiniae. Infect. Immun. 1990, 58:2840-2849.
30. Morishita R., Tomita N., Kaneda Y., Ogihara T. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr. Opin. Pharmacol. 2004, 4:139-146.
31. Neurath M.F., Pettersson S., Meyer zum Bueschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 1996, 2:998-1004.
32. Notley C.A., Inglis J.J., Alzabin S., McCann F.E., McNamee K.E., Williams R.O. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 2008, 205:2491-2497.
33. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
34. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 1998, 160:943-952.
35. Schlaak J.F., Barreiros A.P., Pettersson S., Schirmacher P., Meyer Zum Büschenfelde K.H., Neurath M.F. Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice. Scand. J. Immunol. 2001, 54:396-403.
36. Schmitt C., Villwock A., Kurzai O. Recognition of meningococcal molecular patterns by innate immune receptors. Int. J. Med. Microbiol. 2009, 299:9-20.
37. Silva M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol. 2010, 87:805-813.
38. Simmonds R.E., Foxwell B.M. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology 2008, 47:584-590.
39. Tsai C.M., Frasch C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrilamide gels. Anal. Biochem. 1982, 119:115-119.
40. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 1995, 5:392-399.
41. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
42. Zakharova M., Ziegler H.K. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 2005, 175:5024-5033.